会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NUCLEOTIDE AND PEPTIDE SEQUENCES FOR TREATING MYASTHENIA
    • 用于治疗MYASTHENIA的核苷酸和肽段序列
    • WO1997004093A1
    • 1997-02-06
    • PCT/FR1996001131
    • 1996-07-18
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUECOHEN-KAMINSKY, SylviaBERRIH-AKNIN, Sonia
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    • C12N15/12
    • C07K16/2809A61K39/00A61K2039/51C07K14/7051
    • The use of nucleotide or peptide sequences for preparing drugs suitable for treating or preventing acquired auto-immune myasthenia is disclosed. Said nucleotide sequences are selected from sequences capable of coding for a peptide sequence that is in turn capable of causing the formation of antibodies that recognise and form an immunological complex with all or part of the amino acid sequence of human T cell receptor segment V beta 5.1; or sequences capable of coding for a peptide sequence that itself represents an antibody capable of recognising and forming an immunological complex with all or part of the amino acid sequence of said segment V beta 5.1; sequences capable of coding for an anti-sense RNA that is in turn capable of hybridising with all or part of the mRNA coded for by the DNA sequence coding for the amino acid sequence of said segment V beta 5.1; or sequences capable of hybridising with all or part of the DNA sequence coding for the amino acid sequence of said segment V beta 5.1, or with all or part of the mRNA coded for by said DNA sequence. Said peptide sequences are selected from sequences capable of causing the formation of antibodies that recognise and form an immunological complex with human T cell receptor segment V beta 5.1; or sequences corresponding to antibodies capable of recognising and forming an immunological complex with all or part of the amino acid sequence of T cell receptor segment V beta 5.1.
    • 公开了使用核苷酸或肽序列制备适于治疗或预防所获得的自身免疫性重症肌无力的药物。 所述核苷酸序列选自能够编码肽序列的序列,所述肽序列又能够导致形成识别并与人T细胞受体区段Vβ15.1的全部或部分氨基酸序列形成免疫复合物的抗体 ; 或能够编码肽序列的序列,其本身表示能够识别并与所述片段Vβ15.1的全部或部分氨基酸序列形成免疫复合物的抗体; 能够编码反义RNA的序列,其又能够与编码所述片段Vβ15.1的氨基酸序列的DNA序列编码的全部或部分mRNA杂交; 或能够与编码所述区段V beta 5.1的氨基酸序列的全部或部分DNA序列杂交的序列,或与所述DNA序列编码的全部或部分mRNA相互杂交的序列。 所述肽序列选自能够形成识别并与人T细胞受体区段Vβ15.1形成免疫复合物的抗体的序列; 或对应于能够识别T细胞受体区段V beta 5.1的全部或部分氨基酸序列的免疫复合物的抗体的序列。